Flavonoids with gastroprotective activity.
+3 authors
Journal: 2009/June - Molecules
ISSN: 1420-3049
Abstract:
Peptic ulcers are a common disorder of the entire gastrointestinal tract that occurs mainly in the stomach and the proximal duodenum. This disease is multifactorial and its treatment faces great difficulties due to the limited effectiveness and severe side effects of the currently available drugs. The use of natural products for the prevention and treatment of different pathologies is continuously expanding throughout the world. This is particularly true with regards to flavonoids, which represent a highly diverse class of secondary metabolites with potentially beneficial human health effects that is widely distributed in the plant kingdom and currently consumed in large amounts in the diet. They display several pharmacological properties in the gastroprotective area, acting as anti-secretory, cytoprotective and antioxidant agents. Besides their action as gastroprotectives, flavonoids also act in healing of gastric ulcers and additionally these polyphenolic compounds can be new alternatives for suppression or modulation of peptic ulcers associated with H. pylori. In this review, we have summarized the literature on ninety-five flavonoids with varying degrees of antiulcerogenic activity, confirming that flavonoids have a therapeutic potential for the more effective treatment of peptic ulcers.
Open in
PUBMED | DOI | PMC | Google Scholar | Wikipedia
Relations:
Content
Citations
(49)
Diseases
(1)
Chemicals
(4)
Organisms
(1)
Affiliates
(1)
Similar articles
Articles by the same authors
Discussion board
Molecules. Feb/28/2009; 14(3): 979-1012
Published online Mar/2/2009
PMID: 19305355
PMC: 6253827

Flavonoids with Gastroprotective Activity

Abstract

Peptic ulcers are a common disorder of the entire gastrointestinal tract that occurs mainly in the stomach and the proximal duodenum. This disease is multifactorial and its treatment faces great difficulties due to the limited effectiveness and severe side effects of the currently available drugs. The use of natural products for the prevention and treatment of different pathologies is continuously expanding throughout the world. This is particularly true with regards to flavonoids, which represent a highly diverse class of secondary metabolites with potentially beneficial human health effects that is widely distributed in the plant kingdom and currently consumed in large amounts in the diet. They display several pharmacological properties in the gastroprotective area, acting as anti-secretory, cytoprotective and antioxidant agents. Besides their action as gastroprotectives, flavonoids also act in healing of gastric ulcers and additionally these polyphenolic compounds can be new alternatives for suppression or modulation of peptic ulcers associated with H. pylori. In this review, we have summarized the literature on ninety-five flavonoids with varying degrees of antiulcerogenic activity, confirming that flavonoids have a therapeutic potential for the more effective treatment of peptic ulcers.

Introduction

Peptic ulcers are a common disorder of the entire gastrointestinal tract [1]. They occur mainly in the stomach and the proximal duodenum. They can also occur in the esophagus, jejunum and gastric anastamotic site [2]. A peptic ulcer results from an imbalance between some endogenous aggressive factor(s) [hydrochloric acid, pepsin, refluxed bile, leukotrienes, reactive oxygen species (ROS)] and cytoprotective factors, which include the function of the mucus-bicarbonate barrier, surface active phospholipids, prostaglandins (PGs), mucosal blood flow, cell renewal and migration, nonenzymatic and enzymatic antioxidants and some growth factors [3,4,5,6]. The pathogenesis of gastric ulcers remains widespread, it is multifactorial disease where diverse factors such as a stressful lifestyle, alcohol consumption, use of steroidal and nonsteroidal antiinflammatory drugs (NSAIDs) and drugs which stimulate gastric acid and pepsin secretion, Helicobacter pylori infections, smoking, lower socio-economic status and family history all represent significant risk factors that may contribute to increasing gastric damage [3]. The prevention or cure of peptic ulcers is one of the most important challenges confronting medicine nowadays, as it is certainly a major human illness affecting nearly 8 to 10 % of the global population [7], and of these 5% suffer from gastric ulcers [3]. The prevalence of this disease is higher in men than in women [8].

Although recent advances in our understanding have highlighted the multifactorial pathogenesis of peptic ulcers, secretion of gastric acid is still recognized as a central component of this disease, therefore the main therapeutic target is the control of this secretion using antacids, H2 receptor blockers like ranitidine, famotidine, anticholinergics like pirenzepin, telezipine or proton pump blockers like omeprazole, lansoprazole, etc. [9]. However, gastric ulcer therapy faces nowadays a major drawback because most of the drugs currently available in the market show limited efficacy against gastric diseases and are often associated with severe side effects [10,11].

In this context, the use of medicinal plants is in continuous expansion all over the world for the prevention and treatment of different pathologies, and natural products are recovering space and importance in the pharmaceutical industry as inspiring sources of new potentially bioactive molecules [12]. Clinical research has confirmed the efficacy of several plants for the treatment of gastroduodenal diseases [13,14]. The medicinal properties of many plants are attributed mainly to the presence of flavonoids, but they may be also influenced by other organic and inorganic compounds such as coumarins, alkaloids, terpenoids, tannins, phenolic acids and antioxidant micronutrients, e.g., Cu, Mn, Zn [15,16].

Flavonoids represent a highly diverse class of secondary metabolites comprising about 9,000 structures that have been identified to date. They constitute the largest and most important group of polyphenolic compounds in plants. These compounds are found in all vascular plants as well as in some mosses [17,18]. The term flavonoid is used to describe plant pigments, mostly derived from benzo-γ-pyrone, which is synonymous with chromone (rings A and C in Figure 1) [19,20].

Figure 1
Basic flavonoid structure.

All flavonoids derive their 15-carbon skeletons (C6–C3–C6) from two basic metabolites, malonyl-CoA and p-coumaroyl-CoA. Their crucial biosynthetic reaction is the condensation of three molecules of malonyl-CoA with one molecule of p-coumaroyl-CoA to give a chalcone intermediate [21]. Chalcones act as the precursors for the vast range of flavonoid derivatives found throughout the plant kingdom. Most contain a six-membered heterocyclic ring, formed by Michael-type nucleophilic attack of a phenol group on to the unsaturated ketone giving a flavanone [22]. The first committed step of the flavonoid pathway is catalyzed by chalcone synthase (CHS; see Scheme 1). Chalcones can then be converted into aurones, a subclass of flavonoids found in certain plant species. Beyond CHS, the next step shared by most of the flavonoid biosynthesis pathways is catalyzed by chalcone isomerase (CHI), which catalyzes a stereospecific ring closure isomerization step to form the 2S-flavanones. The flavanones may represent the most important branching point in flavonoid metabolism, because isomerization of these compounds yields the others class of flavonoids [23]. However, the chemical synthesis is carried out mostly by cyclization and condensation of hydroxyacetophenone.

Taking into account the chemical nature of the molecule, and the positions of substituents on rings A, B, and C, the flavonoids are divided into 14 different groups [24]. Seven of these groups – the flavones, flavonols, flavanones, isoflavones, flavanols (catechins), flavanolols, and anthocyanidines – are particularly well known [24,25,26,27].

Flavonoids belong to the recently popular phytochemicals, chemicals derived from plant material with potentially beneficial effects on human health. The therapeutic effects of many traditional medicines may be related in many cases to the presence of these polyphenols [28]. For example, a wide variety of pharmacological activities have been reported for these substances, including antiviral [29], antiallergic [30], antiplatelet [31], antiestrogenic, anticancerogenic, anti-inflammatory, antiproliferative, antiangiogenic, and antioxidant properties, and their ingestion typically produces no or very little toxicity [24]. Flavonoids were also reported to act in the gastrointestinal tract, having antispasmodic [32], anti-secretory, antidiarrhoeal [33] and anti­ulcer properties [34]. Considering the important role of flavonoids in the prevention or reduction of gastric lesions induced by different ulcerogenic agents, this aim of this study was to review the literature on flavonoids with gastroprotective activity. The search was carried out on Pubmed, Schifinder School, Sciency Direct and NAPRALERT (Acronym for Natural Products ALERT) the data bank of The University of Illinois in Chicago, updated to December 2007, using “anti-ulcer flavonoids” as the search term. The references found in the search were later consulted for details on the models or mechanism based bioassays used for testing flavonoids against peptic ulcers.

Scheme 1
A schematic presentation of the flavonoid biosynthetic pathway showing the enzymatic steps leading to the major classes of end products. Enzymes are indicated with standard abbreviations.

Abbreviations: ANR, anthocyanidin reductase; ANS, anthocyanidin synthase (also known as leucoanthocyanidin dioxygenase); CHI, chalcone isomerase; CHR, chalcone reductase; CHS, chalcone synthase; DFR, dihydroflavonol 4-reductase; FNSI and FNSII, flavone synthase I and II; IFR, isoflavone reductase; IFS, isoflavone synthase; LAR, leucoanthocyanidin reductase; GTs, glucosyl transferases [21].

Flavonoids studied in models that investigate anti-ulcer activity

In this literature review, it was possible to identify ninety-five flavonoids, whose gastroprotective activities cover a full range from inactive through weak activity to active and even strong activity. Of the flavonoids found in this study, forty-two were reportedly inactive; however, this inactivity could vary widely according to the experimental model, animal, route of administration and the dose. For example, flavonols like kaempferol, robinin and dactailin showed no gastroprotective effect in experimental models of reserpine [35,36] and restraint stress-induced ulcers in mouse [35], but kaempferol at doses of 50 and 100 mg/kg showed gastroprotective activity, and when the dose was increased to 250 mg/kg, it showed no activity [37]. Similar results were found for nobeletin, a flavone, where doses of 8 and 25 mg/kg protect the gastric mucosa of the rats from injuries induced by ethanol and HCl/ethanol, respectively, but it was only weakly active at a dose of 50 mg/kg in model of aspirin-induced ulcers [38]. Although many of the pharmacological and biochemical actions of flavonoids are attributed to their activities as antioxidants [39], this observed inactivity in high doses may be related to the capacity of flavonoids to act as pro-oxidants. Thus, flavonoids like quercetin, myricetin and kaempferol induce a concentration-dependent decrease of both the nuclear glutathione (GSH) content and glutathione S-transferase (GST) activity in a model system of isolated rat liver nuclei, which could lead to oxidative DNA damage [40], which in turn may be responsible for their mutagenicity and carcinogenicity; this effect may be explained by the pro-oxidant effects of this compounds [40, 41]. Nevertheless, the structural features that might determine the pro-oxidant activity of these compounds are not well established.

Chalcones belong to flavonoid class with the largest number of compounds with gastroprotective activity. In this review were found thirty-eight, among which we can mention sophoradin, an isoprenyl chalcone, which is present in a Chinese crude drug (the root of Sophora subprostrata) and protects the gastric mucosa from lesions induced by pylorus-ligation and water-immersion stress [42,43]. Thirty sophoradin analogs have shown anti-ulcer effects in the same ulcer induction models. Several chalcones, all having more than one isoprenyloxyl group, exhibited high inhibitory ratios. In particular, 2’,4’-dihydroxy-3’-(3-methyl-2-butenyl)-4-(3-methyl-2-butenyloxy) chalcone, 2’-hydroxy-4,4’-bis(3-methyl-2-butenyloxy) chalcone and 2’-carboxymethoxy-4,4’-bis(3-methyl-2-butenyloxy) chalcone (sofalcone), showed strong activity at a dose of 100 mg/kg, with a high percentage of inhibition of lesions (70-100%), when compared to other chalcones at the same dose and were as potent as sophoradin [42]. Sofalcone is one of these analogs that in addition to its gastroprotective effects also accelerates ulcer healing [44]. The mechanisms of action involved in gastric protection are increased gastric blood flow, stimulated synthesis of mucosubstances of the gastric mucosa [45] and increasing effects on gastric tissue PGs contents [46]. Besides its cytoprotective effects, sofalcone has a direct bactericidal effect on H. pylori, with a minimum inhibitory concentration of 55-222 µmol/L, anti-urease activity and it reduces the adhesion of this organism to gastric epithelial cells [47,48]. When outpatients with peptic ulcers and H. pylori infections were medicated for 7 d with sofalcone (100 mg thrice daily) plus the triple therapy with rabeprazole (10 mg twice daily), clarithromycin (200 mg twice daily) and amoxicillin (750 mg twice daily), sofalcone significantly increased the cure rate of H. pylori infections [49]. Therefore flavonoids can be utilized as alternative or additive agents to the current therapy in treatment of peptic ulcer induced by H. pylori infection.

Another flavonoid that appears to exert anti-ulcer activity is monomeric leucocyanidin, a natural flavonoid and the major component present in unripe plantain banana (Musa sapientum L. var. paradisiaca). It and its synthetic analogues hydroxyethylated leucocyanidin and tetrallylleucocyanidin showed protective effects against aspirin-induced gastric erosions in a prophylactic animal model, as shown by the absence of mucosal damage and a significant reduction in the ulcer index, when added to the diet at 5 mg and 15 mg per day [50,51]. The authors concluded that these compounds may be responsible for the displayed anti-ulcer properties and they suggested that the mechanism by which the active agent present in plantain banana and its synthetic analogues protects the mucosa is mediated, at least in part, by an increase in mucus thickness [51].

Another polyphenolic compound with relevant activities is garcinol, a polyisoprenylated benzophenone derivative from Garcinia indica, which shows potent free radical scavenging activity in three kinds of free radical generating systems. In the hypoxanthine/xanthine oxidase system, emulsified garcinol suppressed superoxide anion to almost the same extent as dl-α-tocopherol by weight and also suppressed hydroxyl radical more strongly than dl-α-tocopherol in the Fenton reaction system. In the H2O2/NaOH/DMSO system, this compound suppressed superoxide anion, hydroxyl radical, and methyl radical. Orally administered garcinol prevented acute ulceration in rats induced by indomethacin (40-200 mg/kg) and water immersion stress (200 mg/kg) caused by radical formation. These results suggested that garcinol might have potential as a free radical scavenger and clinical applications as an anti-ulcer drug. Although the mechanism of its anti-ulcer activity is not yet understood, garcinol may scavenge reactive oxygen species on the surface of gastric mucosa, thus protecting cells from injury [52].

A flavonoid that has been studied in some detail is rutin (quercetin-3-rhamnosylglucoside), a natural flavone derivative. It has been reported to prevent gastric mucosal ulceration in animal models including reserpine [35], acidified ethanol [37] and absolute and 50% ethanol [34,37]. The cytoprotective effect of this flavonoid does not appear to be mediated by endogenous prostaglandins [53], but its protective effects may be mediated by endogenous platelet-activating factor (PAF), since it inhibited dose-dependently the mucosal content of PAF [37]. Another possible mechanism involves the antioxidant properties of rutin, which at a dose of 200 mg/kg has a protective effect against lesions induced by 50 % ethanol, probably by reducing the levels of lipoperoxides and increasing the activity of the antioxidant enzyme glutathione peroxidase (GSH-Px). However, no significant modifications were observed in the gastric non-protein sulfhydryl (SH) content or in the ethanol-induced leukocyte infiltrate [34].

One of the most studied flavonoids is quercetin (3,3’,4’,5,7-pentahydroxyflavone). It protects the gastrointestinal mucosa from acute lesions induced by various experiemental models and against different necrotic agents, including restraint stress [37,54,55] pylorus-ligation [56], reserpine [35,36,55,57], aspirin [54], indomethacin [58], acid-ethanol [37] and ethanol-induced gastric ulcers [54,59,60]. Its gastroprotective action mechanism involves endogenous PAF [37], an increase in mucus production [58], antihistaminic properties, which decrease histamine levels and reduction of the number of ethanol-induced mast cells. It also inhibits H. pylori growth, the formation of acid by parietal cells in response to stimulation by histamine and dibutyryl cyclic AMP, as well as the gastric H+/K+ proton pump (data not shown in Table 1) [61]. The main mechanism of action for the gastroprotective effects of this flavonol are its antioxidant properties, since oral pretreatment with quercetin (200 mg/kg) had protective effects in that it significantly reduced the severity of ethanol-induced ulcers by inhibition of lipid peroxidation, enhancement in the levels of mucosal non-protein SH compounds (important antioxidant agents) [59,60] in GSH-Px [59] and superoxide dismutase activities, as well as reduction of protein carbonyl compounds [60]. At a dose of 100 mg/kg twice daily for 5 days it also decreases lipid peroxidation and plasmatic corticosterone in a restraint stress model. This flavonoid, in addition to protecting the gastric mucosa in acute models of ulcer induction, when administered chronically both quercetin and naringenin also promote healing of gastric ulcers induced by acetic acid, a chronic model of ulcer [62]. The antioxidant mechanism of action of flavonoids, especially garcinol, rutin and quercetin, is due mainly the presence in their structures of an o-dihydroxy in the B ring (catechol), and additionally a 2,3 double bond in conjugation with a 4-oxo function, as well as the presence of hydroxyl groups in positions 3, 5 and 7 [24,63,64]

Finally, nowadays it is known that NSAIDs, such as piroxicam or aspirin have several adverse effects on the gastrointestinal tract and increase the risk of myocardial infarction. However, several flavonoids have demonstrated anti-inflammatory properties, without showing any ulcerogenic action as a side effect, and thus showing a great advantage in the treatment of peptic ulcers.

molecules-14-00979-t001_Table 1Table 1
Flavonoids with gastroprotective activity.
SubstanceExperimental assay/Administration routeAnimal testedDoseActivity
Chalcones
Butein
HCl/ethanol-induced ulcers/intragastricRat10 mg/kgActive [65]
NaOH-induced ulcers/intragastricRat50.0 mg/kgInactive [65]
2',3,4,4',6'-pentahydroxychalcone
HCl/ethanol-induced ulcers/intragastricRat10.0 mg/kgActive [65]
NaOH-induced ulcers/intragastricRat10.0 mg/kgActive [65]
2',3,4-trihydroxychalcone
HCl/ethanol-induced ulcers/intragastricRat10.0 mg/kgActive [65]
NaOH-induced ulcers/intragastricRat10.0 mg/kgActive [65]
2',4',6'-trihydroxychalcone
HCl/ethanol-induced ulcers/intragastricRat10.0 mg/kgActive [65]
NaOH-induced ulcers/intragastricRat10.0 mg/kgActive [65]
2',4'-dihydroxy-3',5'-diprenyl-4-O-prenyl- chalcone
Stress-induced ulcers (water-immersion)/i.p.Rat100.0 mg/kgActive [42]
2',4'-dihydroxy-3'-methoxychalcone
Ethanol-induced ulcers/intragastricMouse*Weak Active [66]
Ethanol-induced ulcers/intragastricRat100.0 mg/kgActive [67]
Ethanol-induced ulcers/intragastricRat*Active [66]
2',4'-dihydroxy-5'-prenyl-4-O-prenyl- chalcone
Pylorus ligation-induced ulcers/i.p.Rat100.0 mg/kgActive [42]
Stress-induced ulcers (water-immersion)/i.p.Rat100.0 mg/kgActive [42]
2',4'-dihydroxychalcone
Stress-induced ulcers (water-immersion)/intragastricRat10.0 mg/kgActive [65]
Acetic acid-induced ulcers/intragastricRat10.0 mg/kgActive [65]
HCl/ethanol-induced ulcers/intragastricRat10.0 mg/kgActive [65]
NaOH-induced ulcers/intragastric
Ethanol-induced ulcers/intragastricRat10.0 mg/kgActive [65]
Ethanol-induced ulcers/intragastricMouse*Active [66]
Ethanol-induced ulcers/intragastricRat100 mg/kgActive [67]
Rat*Active [66]
2',4,4',6'-tetrahydroxychalcone
HCl/ethanol-induced ulcers/intragastricRat10.0 mg/kgInactive [65]
NaOH-induced ulcers/intragastricRat10.0 mg/kgActive [65]
2',4,4'-trihydroxy-3,3',5'-tris-(3-methyl-but-2-enyl) chalcone
*/*Rat*Active [68]
2',4,4'-trihydroxy-3,3',5,5'-tetrakis-(3-methyl-but-2-enyl)-4,4'-bis-(O-3-methyl-but-2-enyl) chalcone
*/*Rat*Active [69]
2',4,4'-trihydroxy-3,3',5,5'-tetrakis-3-methyl-but-2-enyl) chalcone
*/*Rat*Active [68]
2',4,4'-trihydroxy-3,3',5-tris-(3-methyl-but-2-enyl)-4-4'-di-O-allyl chalcone
*/*Rat*Active [69]
2',4,4'-trihydroxy-3,3'-bis-(3-methylbut-2-enyl) chalcone
*/*Rat*Active [68]
2',4,4'-trihydroxy-3,3'-diprenylchalcone
Stress-induced ulcers (water-immersion)/i.p.Rat100.0 mg/kgActive [42]
2',4,4'-trihydroxy-3,5,5'-tris-(3-methyl-but-2-enyl)-4'-O-(3-methylbut-2-enyl) chalcone
*/*Rat*Active [69]
2',4,4'-trihydroxychalcone
HCl/ethanol-induced ulcers/intragastricRat10.0 mg/kgActive [65]
NaOH-induced ulcers/intragastricRat10.0 mg/kgActive [65]
2',4-dihydroxy-3-prenyl-4'-O-prenyl- chalcone
Stress-induced ulcers (water-immersion)/i.p.Rat100.0 mg/kgActive [42]
2',4-dihydroxy-4'-methoxy-3-5-bis-(3-methyl-but-2-enyl) chalcone
*/*Rat*Active [42]
2'-carbomethoxy-4,4'-bis-(3-methyl-2-butenyl-oxy) chalcone (sofalcone)
Histamine-induced ulcers/i.p.Rat100.0 mg/kgActive [45]
Acetic acid-induced ulcers/gastric intubationRat20-50 mg/kgActive [45]
Histamine-induced ulcers/gastric intubationGuinea pig100.0 mg/kgActive [45]
Pylorus ligation-induced ulcers/i.p.Rat50.0 mg/kgActive [45]
Stress-induced ulcers (water-immersion)/i.p.Rat50.0 mg/kgActive [45]
Phenylbutazone-induced ulcers/gastric ntubationRat300.0 mg/kgActive [45]
Acetic acid-induced ulcers/gastric intubationRat50.0 mg/kgActive [44]
HCl induced gastric lesions/i.p.Rat100.0 mg/kgActive [46]
HCl induced gastric lesions/gastric intubationRat100.0 mg/kgActive [46]
Pretreatment with indomethacin vs HCl induced gastric lesions/gastric intubationRat300.0 mg/kgActive [46]
Pretreatment with indomethacin vs HCl induced gastric lesions/i.p.Rat100.0 mg/kgActive [46]
H. pylori induced ulcer/p.o.Human adult100.0 mg/kgActive [49]
2'-hydroxy-4,4'-di-O-prenylchalcone
Pylorus ligation-induced ulcers/i.p.Rat100.0 mg/kgStrong activity [42]
Stress-induced ulcers (water-immersion)/i.p.Rat100.0 mg/kgStrong activity [42]
2,4'-di-O-prenylchalcone
Pylorus ligation-induced ulcers/i.p.Rat100.0 mg/kgActive [42]
Stress-induced ulcers (water-immersion)/i.p.Rat100.0 mg/kgWeak activity [42]
2,4,4'-trihydroxy-3,3',5'-tris-(3-methyl-but-2-enyl)-4-O-allyl-4-O-propargyl-chalcone
*/*Rat*Active [69]
3',5'-dihydroxy-4'-prenyl-5-O-prenyl- chalcone
Pylorus ligation-induced ulcers/i.p.Rat100.0 mg/kgStrong activity [42]
Stress-induced ulcers (water-immersion)/i.p.Rat100.0 mg/kgStrong activity [42]
3,3',4-trihydroxychalcone
HCl/ethanol-induced ulcers/intragastricRat10.0 mg/kgActive [65]
NaOH-induced ulcers/intragastricRat10.0 mg/kgActive [65]
3,4,4'-trihydroxychalcone
HCl/ethanol-induced ulcers/intragastricRat10.0 mg/kgInactive [65]
NaOH-induced ulcers/intragastricRat10.0 mg/kgActive [65]
4'-hydroxy-3'-prenyl-4-O-prenylchalcone
Pylorus ligation-induced ulcers/i.p.Rat100.0 mg/kgActive [42]
Stress-induced ulcers (water-immersion)/i.p.Rat100.0 mg/kgStrong activity [42]
4,4'-di-O-geranyl chalcone
Pylorus ligation-induced ulcers/i.p.Rat100.0 mg/kgWeak activity [42]
Stress-induced ulcers (water-immersion)/i.p.Rat100.0 mg/kgWeak activity [42]
4,4'-di-O-prenylchalcone
Pylorus ligation-induced ulcers/i.p.Rat100.0 mg/kgActive [42]
Stress-induced ulcers (water-immersion)/i.p.Rat100.0 mg/kgStrong activity [42]
4,4'-dihydroxy-3,3'-diprenylchalcone
Stress-induced ulcers (water-immersion)/i.p.Rat100.0 mg/kgActive [42]
4,4'-dimethoxy-3,3'-diprenylchalcone
Pylorus ligation-induced ulcers/i.p.Rat100.0 mg/kgWeak activity [42]
Stress-induced ulcers (water-immersion)/i.p.Rat100.0 mg/kgActive [42]
4-hydroxy-3-prenyl-4'-O-prenylchalcone
Pylorus ligation-induced ulcers/i.p.Rat100.0 mg/kgActive [42]
Stress-induced ulcers (water-immersion)/i.p.Rat100.0 mg/kgWeak activity [42]
2',4-bis-(carbomethoxy)-4'-(3-carboxy-2-butenyl-oxy) dihydrochalcone
Pylorus ligation-induced ulcers/i.p.Rat100.0 mg/kgWeak activity [70]
Stress-induced ulcers (water-immersion)/i.p.Rat100.0 mg/kgWeak activity [70]
Histamine-induced ulcers/i.p.Rat100.0 mg/kgWeak activity [70]
2',4-bis-(carboxymethoxy)-4'-(3-methyl-2-butenyl-oxy) dihydrochalcone
Pylorus ligation-induced ulcers/i.p.Rat100.0 mg/kgActive [70]
Stress-induced ulcers (water-immersion)/i.p.Rat100.0 mg/kgWeak activity [70]
Histamine-induced ulcers/i.p.Rat100.0 mg/kgActive [70]
2'-carboxymethoxy-4-4'-bis-(3-methyl-2-butenyl-oxy) dihydro-chalcone
Pylorus ligation-induced ulcers/i.p.Rat100.0 mg/kgActive [70]
Stress-induced ulcers (water-immersion)/i.p.Rat100.0 mg/kgActive [70]
Histamine-induced ulcers/i.p.Rat100.0 mg/kgActive [70]
Garcinol
Stress-induced (restraint) ulcers/intragastricRat200.0 mg/kgActive [52]
Indomethacin-induced ulcers/intragastricRat200.0 mg/kgActive [52]
Sophoradin
Pylorus ligation-induced ulcers/p.o.Rat*Active [43]
Stress-induced ulcers/p.o.Rat*Active [43]
Pylorus ligation-induced ulcers/p.o.Rat100.0 mg/kgStrong activity [42]
Stress-induced ulcers/p.o.Rat100.0 mg/kgStrong activity [42]
Xanthoangelol E
Stress-induced (restraint) ulcers/intragastricRat100.0 mg/kgActive [71]
Flavanones
3',4',5,7-tetrahydroxy-3-methoxy- flavanone
stress-induced (restraint) ulcers/*Rat*Active [72]
2',4',7-trihydroxy-5-methoxy-8-(5-hydroxy-5-methyl-2-iso-propenyl-hexyl) flavanone
*/p.o.Human adult*Active [73]
Hesperidin
Cold stress-induced ulcers/intragastricRat100.0 mg/kgActive [74]
Ethanol-induced ulcers/intragastricRat100.0 mg/kgInactive [74]
Naringenin
Acetic acid-induced ulcers/intragastricRat100.0 mg/kgActive [62]
Stress-induced ulcers (water-immersion)/intragastricRat100.0 mg/kgWeak active [56]
Pylorus ligation-induced ulcers/intragastricRat100.0 mg/kgActive [56]
Pylorus ligation-induced ulcers /intragastricRat100.0 mg/kgActive [56]
Pylorus ligation-induced ulcers/gastric intubationRatED50 132 mg/kgActive [75]
Stress-induced (restraint) ulcers/gastric intubationRatED50 42.0 mg/kgActive [75]
Aspirin-induced ulcers/gastric intubationRat*Active [75]
Phenylbutazone-induced ulcers/gastric intubationRat*Active [75]
Reserpine-induced ulcers/gastric intubationRat*Active [75]
Naringin
Aspirin-induced ulcers/intragastricRat200.0 mg/kgActive [76]
Acid-ethanol-induced ulcers/i.p.Rat100.0 mg/kgInactive [37]
Acid-ethanol-induced ulcers/i.p.Rat200.0 mg/kgActive [37]
Acid-ethanol-induced ulcers/i.p.Rat400.0 mg/kgActive [37]
Ethanol-induced gastric injury/intragastricRat400.0 mg/kgActive [37]
Sigmoidin A
Stress-induced ulcers (water-immersion)/gastric intubationRat50.0 mg/kgActive [78]
Stress-induced (restraint) ulcers/gastric intubationRat50.0 mg/kgActive [78]
Sigmoidin B
Stress-induced ulcers (water-immersion)/gastric intubationRat50.0 mg/kgActive [78]
Stress-induced (restraint) ulcers/gastric intubationRat50.0 mg/kgActive [78]
Sophoranone
Pylorus ligation-induced ulcers/p.o.Rat*Active [43]
Stress-induced ulcers/p.o.Rat*Active [43]
Flavane and Flavanols
(+) catechin
HCl/ethanol-induced stomach ulcers/intragastricRat*Inactive [79]
*/pathway oral (p.o.)Rat100.0 mg/kgActive [80]
Reserpine-induced ulcers/gastric intubationMouse49.7 mg/kgEquivocal [57]
Reserpine-induced ulcers/gastric intubationMouse72.5 mg/kgInactive [57]
Stress-induced ulcers (water-immersion)/gastric intubationMouse500.0 mg/kgWeak Active [81]
(dl) catechin
Stress-induced (restraint) ulcers/subcutaneous (s.c.)Mouse300.0 mg/kgActive [82]
Stress-induced (restraint) ulcers/intragastricMouse300.0 mg/kgActive [82]
Stress-induced ulcers (water-immersion)/s.c.Mouse300.0 μmol/kgActive [82]
Stress-induced ulcers (water-immersion)/intragastricMouse300.0 mg/kgActive [82]
3-O-methyl: (+) catechin
Pylorus ligation-induced ulcers/s.c.RatED50 60.0 mg/kgActive [83]
Stress-induced (restraint) ulcers/s.c.RatED50 13.2 mg/kgActive [83]
*/s.c.Rat*Active [83]
Phenylbutazone-induced ulcers/s.c.Rat*Active [83]
Reserpine-induced ulcers/s.c.Rat*Active [83]
*/***Active [84]
(-) Epicatechin
Stress-induced ulcers (water-immersion)/gastric intubationMouse500.0 mg/kgWeak Active [81]
(+) Cyanidan-3-beta- ol
Pylorus ligation-induced ulcers/s.c.RatED50 62 mg/kgActive [85]
Restraint-induced ulcers/s.c.RatED50 18 mg/kgActive [85]
Aspirin-induced ulcers/gastric intubationRat100.0 mg/kgActive [85]
Phenylbutazone-induced ulcers/gastric intubationRat100.0 mg/kgActive [85]
Ibuprofen-induced ulcers/gastric intubationRat100.0 mg/kgActive [85]
Reserpine-induced ulcers/gastric intubationRat100.0 mg/kgActive [85]
Leucocyanidin
Aspirin-induced ulcers/*Rat5.0 mg/dayActive [50]
*/intragastricRat*Active [51]
Flavanolols
Taxifolin
Ethanol induced gastric ulcers/intragastricRat50.0 mg/kgActive [86]
Taxifolin,(dl)
HCl /ethanol-induced stomach ulcers/intragastricRat* mg/kgInactive [79]
Anthocyanidines
Benzopyrylium chloride,1: 3,5,7- trihydroxy-2-(3-4-dihydroxyphenyl)
Pylorus ligation-induced ulcers/intragastricRat12.5 mg/kgActive [87]
Stress-induced (restraint) ulcers/intragastricRat100.0 mg/kgActive [87]
Phenylbutazone-induced ulcers/intragastricRat22.0 mg/kgActive [87]
Indomethacin-induced ulcers/intragastricRat100.0 mg/kgActive [87]
Reserpine-induced ulcers/intragastricRat100.0 mg/kgActive [87]
Ethanol induced lesion/intragastricRat200.0 mg/kgActive [87]
Histamine-induced ulcers/intragastricRat24.0 mg/kgActive [87]
Cysteamine-induced ulcers/intragastricRat200.0 mg/kgActive [87]
Cysteamine-induced ulcers/intraperitoneal (i.p.)Rat50.0 mg/kgActive [87]
Acetic acid-induced ulcers/intragastricRat50.0 mg/kgActive [87]
Flavones
Acacetin
Reserpine-induced ulcers/gastric intubationMouse0.05 mL/gInactive [36]
Apigenin
Reserpine-induced ulcers/gastric intubationMouse0.05 mL/gInactive [36]
Cynaroside
*/intragastricRat** [88]
Dactylin
Reserpine-induced ulcers/gastric intubationMouse*Inactive [35]
Stress-induced (restraint) ulcers/gastric intubationMouse*Inactive [35]
Eupatilin
*/ IntragastricRat*Active [89]
Gnaphaloside A
Reserpine-induced ulcers/gastric intubationMouse0.05 mL/gActive [36]
Gossypin
*/oralRat100.0 mg/kgActive [80]
Hyperoside
Reserpine-induced ulcers/gastric intubationMouse*Weak activity [35]
Stress-induced (restraint) ulcers/gastric intubationMouse*Weak activity [35]
Hypolaetin-8-O-beta-d-glucoside
Cold stress-induced ulcers/i.p.RatED50 573mg/kgActive [90]
Cold stress-induced ulcers/**ED50 57.3mg/kgActive [91]
Ethanol-induced gastric lesions/s.c.RatED50 68.0mg/kgActive [92]
Kaempferol rhamnoside
Reserpine-induced ulcers/gastric intubationMouse0.05 mL/gActive [36]
Linarin
Reserpine-induced ulcers/gastric intubationMouse0.05 mL/gInactive [36]
Luteolin
*/intragastricRat*Active [88]
Reserpine-induced ulcers/gastric intubationMouse47.4 mg/kgActive [57]
Reserpine-induced ulcers/gastric intubationMouse474 mg/kgActive [57]
Myricetin rhamnoside
Reserpine-induced ulcers/gastric intubationMouse0.05 mL/gActive [36]
Nobiletin
Ethanol-induced gastric ulcer/intragastricRatED50 8.0 mg/kgActive [38]
Ethanol-induced ulcers/intragastricRatED50 8.0 mg/kgActive [93]
Aspirin-induced ulcers/intragastricRat50.0 mg/kgWeak active [93]
HCl/ethanol-induced gastric ulcers/intragastricRat25.0 mg/kgActive [97]
Pectolinarigenin
Reserpine-induced ulcers/gastric intubationMouse0.05 mL/gInactive [36]
Pectolinarin
Reserpine-induced ulcers/gastric intubationMouse0.05 mL/gInactive [36]
Acetyl pectolinarin
Reserpine-iduced ulcers/gastric itubationMouse0.05 mL/gInactive [36]
Quercetin rhamnoside
Reserpine-induced ulcers/gastric intubationMouse0.05 mL/gActive [36]
Quercitrin
Reserpine-induced ulcers/gastric intubationMouse50.0 mg/gActive [57]
Robinin
Reserpine-induced ulcers/gastric intubationMouse*Inactive [36]
Stress-induced (restraint) ulcers/gastric intubationMouse*Inactive [36]
Rutin
Acid-ethanol-induced ulcers/i.p.Mouse12.5 mg/kgInactive [37]
Acid-ethanol-induced ulcers/i.p.Rat25.0 mg/kgActive [37]
Acid-ethanol-induced ulcers/i.p.Rat50.0 mg/kgActive [37]
Pretreatment with indomethalin vs ethanol induced-ulcers/intragastricRat25.0 mg/kgWeak activity [53]
Ethanol-induced ulcers/intragastricRat50.0 mg/kgActive [53]
Ethanol-induced ulcers/ intragastricRat200.0 mg/kgActive [34]
*/intragastricMouse7.0 mg/kgActive [95]
*/intragastricMouse*Active [96]
Reserpine-induced ulcers/gastric intubationMouse*Weak activity [35]
Stress-induced (restraint) ulcers/gastric intubationMouse*Weak activity [35]
Salvigenin
Pylorus ligation-induced ulcers/i.p.Rat100.0 mg/kgInactive [97]
Scoparin
Reserpine-induced ulcers/gastric intubationMouse0.05 mL/gInactive [36]
Ternatin
Cold stress-induced ulcers/i.p.Rat25.0 mg/kgInactive [98]
Ethanol-induced ulcers/i.p.Rat25.0 mg/kgInactive [98]
Indomethacin-induced ulcers/i.p.Rat25.0 mg/kgInactive [98]
Vexibinol
HCl-ethanol induced ulcers/intragastricRat10.0 mg/kgActive [99]
Stress-induced ulcers (water-immersion)/intragastricRat10.0 mg/kgActive [99]
Pylorus ligation-induced ulcers/intragastricRat100.0 mg/kgActive [99]
Indomethacin-induced ulcers/intragastricRat100.0 mg/kgActive [99]
Histamine-induced ulcers/intragastricRat100.0 mg/kgInactive [99]
5-Ht-induced ulcers/intragastricRat300.0 mg/kgInactive [99]
Phenylbutazone induced ulcers/intragastricRat300.0 mg/kgActive [99]
Isoflavones
Genistin
*/intragastricRat*Active [88]
Flavonols
Kaempferol
Acid-ethanol-induced ulcers/i.p.Rat250.0 mg/kgInactive [37]
Acid-ethanol-induced ulcers/i.p.Rat50.0 mg/kgActive [37]
Acid-ethanol-induced ulcers/i.p.Rat100.0 mg/kgActive [37]
Ethanol-induced ulcers/i.p.Rat100.0 mg/kgActive [100]
Cold stress-induced ulcers/i.p.Rat200.0 mg/kgActive [100]
Reserpine-induced ulcers/gastric intubationMouse0.05 mL/gInactive [36]
Pylorus ligation-induced ulcers/i.p.Rat200.0 mg/kgActive [101]
Stress-induced (restraint) ulcers/i.p.Rat200.0 mg/kgActive [101]
Reserpine-induced ulcers/gastric intubationMouse*Inactive [35]
Stress-induced (restraint) ulcers/gastricMouse*Inactive [35]
Myricetin
Reserpine-induced ulcers/gastric intubationMouse0.05 mL/gInactive [36]
Reserpine-induced ulcers/gastric intubationMouse0.05 mL/gActive [36]
Reserpine-induced ulcers/gastric intubationMouse*Active [55]
Stress-induced (restraint) ulcers/gastric intubationMouse*Active [55]
Reserpine-induced ulcers/gastric intubationMouse*Active [35]
Stress-induced (restraint) ulcers/gastric intubationMouse*Active [35]
Patuletin
Reserpine-induced ulcers/gastric intubationMouse0.05 mL/gInactive [36]
Patulitrin
Reserpine-induced ulcers/gastric intubationMouse0.05 mL/gWeak active [36]
Phellavin
Reserpine-induced ulcers/gastric intubationMouse0.05 mL/gInactive [36]
Quercetin
Ethanol-induced gastric lesions/intragastricRat200.0 mg/kgActive [59]
Acetic acid-induced ulcers/intragastricRat100.0 mg/kgActive [62]
Stress-induced ulcers (water-immersion)/intragastricRat100.0 mg/kgActive [56]
Pylorus ligation-induced ulcers/intragastricRat100.0 mg/kgActive [56]
Pylorus ligation-induced ulcers/intragastricRat100.0 mg/kgActive [56]
*/intragastricRat200.0 mg/kgActive [58]
Acid-ethanol-induced ulcers/i.p.Rat12.5 mg/kgInactive [37]
Acid-ethanol-induced ulcers/i.p.Rat25.0 mg/kgActive [37]
Acid-ethanol-induced ulcers/i.p.Rat50.0 mg/kgActive [37]
Ethanol-induced gastric ulcers/i.p.Rat12.5 mg/kgActive [104]
*/ intragastricMouse*Active [96]
Ethanol-induced ulcers/intragastricRat100.0 mg/kgActive [54]
Stress-induced (restraint) ulcers/intragastricRat100.0 mg/kgActive [54]
Ethanol-induced ulcers/intragastricRat200.0 mg/kgActive [60]
Reserpine-induced ulcers/gastric intubationMouse0.05 mL/gmInactive [36]
Reserpine-induced ulcers/gastric intubationMouse50.0 mg/kg* [57]
Reserpine-induced ulcers/gastric intubationMouse*Active [55]
Stress-induced (restraint) ulcers/gastricMouse*Active [55]
Reserpine-induced ulcers/gastric intubationMouse*Active [35]
Stress-induced (restraint) ulcers/gastric intubationMouse*Active [35]
Quercetin-3'-o-beta-d-glucoside
Reserpine-induced ulcers/gastric intubationMouse0.05 mL/gInactive [36]
Biflavonoids
Cinnamtannin B-1
Stress-induced ulcers (water-immersion)/gastric intubationMouse500.0 mg/kgInactive [81]
Cinnamtannin D-1
Stress-induced ulcers (water-immersion)/gastric intubationMouse500.0 mg/kgInactive [81]
Procyanidin B-1
Stress-induced ulcers (water-immersion)/gastric intubationMouse500.0 mg/kgWeak activity [81]
Procyanidin B-2
Stress-induced ulcers (water-immersion)/gastric intubationMouse200.0 mg/kgActive [81]
Procyanidin B-3
HCl/ethanol-induced stomach ulcers/intragastricRat200.0 mg/kgInactive [79]
Procyanidin B-4
Stress-induced ulcers (water-immersion)/gastric intubationMouse500.0 mg/kgActive [81]
* Dates weren’t provided

Conclusions

Flavonoids represent a highly diverse class of secondary metabolites with potentially beneficial effects on human health. These compounds protect the gastrointestinal mucosa from lesions produced by various experimental ulcer models and against different necrotic agents. Several mechanisms of action may be involved in this protective effect. Quercetin has an anti-secretory mechanism of action. This flavonol has antihistaminic properties, thus, decreases histamine levels, as well as preventing the release of histamine from gastric mast cells and inhibiting the gastric H+/K+ proton pump, diminishing acid gastric secretion. On the other hand chalcones, in particular those with more than one isoprenyloxyl group, possess cytoprotective effects, which increase the mucosal blood flow, stimulate the synthesis of mucosubstances in the gastric mucosa and increase PGs levels. However, the most important mechanism of action responsible for the anti-ulcer activity of flavonoids is their antioxidant properties, seen in garcinol, rutin and quercetin, which involves free radical scavenging, transition metal ions chelation, inhibition of oxidizing enzymes, increase of proteic and nonproteic antioxidants and reduction of lipid peroxidation. These effects are correlated with presence in the structures of an o-dihydroxy in the ring B (catechol), and additionally a 2,3 double bond in conjugation with a 4-oxo function, as well as the presence hydroxyl groups in positions 3, 5 and 7. Besides the gastroprotective activity, sofalcone (a chalcone), quercetin and naringenin (flavanones) accelerate the healing of gastric ulcers. In addition, the two first polyphenolic compounds have anti-H. pylori activity and may be utilized as an alternative or additive agent to the current therapy. Therefore flavonoids could have an ideal more effective and less toxic therapeutic potential for the treatment of gastrointestinal diseases, particularly for peptic ulcers.

Footnotes

Sample availability: Not available.

Acknowledgements

The authors would like to express their sincere thanks to Ms. Gabriela G. Barbosa for the revision of the English grammar and to College of Pharmacy, the University of Illinois at Chicago, U.S.A., for helping with the computer in the database NAPRALERT.

References

  • 1. MaytyP.BiswasK.RoyS.BarnergeeR. K.BandyopadhyayU.Smoking and pathogenesis of gastroduodenal ulcer-recent mechanistic updateMol. Cell. Biochem.2003253329338[PubMed][Google Scholar]
  • 2. PradosC. M.A.MiquelD.B.Úlcera pépticaRev. Esp. Enferm. Dig.2004968182[PubMed][Google Scholar]
  • 3. BandyopadhyayD.BiswasK.BhattacharyyaM.ReiterR.J.BanerjeeR.K.Gastric toxicity and mucosal ulceration induced by oxygen-derived reactive species, protection by melatoninCurr. Mol. Med.20011501513[PubMed][Google Scholar]
  • 4. BhattacharjeeM.BhattacharjeeS.GuptaA.BanerjeeR.K.Critical role of an endogenous gastric peroxidase in controlling oxidative damage in H. pylori-mediated and non-mediated gastric ulcerFree Radical Biol. Med.200232731743[PubMed][Google Scholar]
  • 5. KonturekP.C.KonturekS.Role of Helicobacter pylori infection in gastro-duodenal secretion and in pathogenesis of peptic ulcer and gastritisJ. Physiol. Pharmacol.199445333350[PubMed][Google Scholar]
  • 6. WallaceJ.L.GrangerD.N.The cellular and molecular basis of gastric mucosal defenseFASEB J.199610731740[PubMed][Google Scholar]
  • 7. CalamJ.BaronJ. H.Pathophysiology of duodenal and gastric ulcer and gastric cancerBrit Med J.2001323980983[PubMed][Google Scholar]
  • 8. LiuC.CrawfordJ. M.Patologia–Bases patológicas das doençasRobbins & Cotran.KumarV.AbbasA.K.FaustoN.ElsevierRio de Janeiro, Brazil2005Volume 7851857[Google Scholar]
  • 9. RaoC.H.V.OjhaS.K.RadhakrishnanK.GovindarajanR.RastogiS.MehrotraS.PushpangadanP.Antiulcer activity of Utleria salicifolia rhizome extractJ. Ethnopharmacol.200491243249[PubMed][Google Scholar]
  • 10. BandyopadhyayD.BiswasK.BhattacharyyaM.ReiterR.J.BanerjeeR.K.Involvement of reactive oxygen species in gastric ulceration, protection by melatoninIndian J. Exp. Biol.200240693705[PubMed][Google Scholar]
  • 11. LehneR.A.Pharmacology for Nursing CareW.B. SaundersPhiladelphia, USA1998781783
  • 12. Cechinel-FilhoV.YunesR.A.Breve análise histórica da Química de Plantas Medicinais: Sua importância na atual concepção de fármaco segundo os paradigmas Ocidental e OrientalPlantas medicinais sob a ótica da química medicinal modernaYunesR.A.CalixtoJ.B.Argos Editora UniversitáriaChapecó, Brazil2001[Google Scholar]
  • 13. KannerJ.LapidotT.The stomach as a bioreactor: dietary lipid peroxidation in the gastric fluid and the effects of plantderived antioxidantsFree Radical Biol. Med.20013113881395[PubMed][Google Scholar]
  • 14. GurbuzI.AkyuzC.YesiladaE.SenerB.Anti-ulcerogenic effect of Momordica charantia L. fruits on various ulcer models in ratsJ. Ethnopharmacol.2000717782[PubMed][Google Scholar]
  • 15. Cechinel FilhoV.YunesR.A.Estratégias para a obtenção de compostos farmacologicamente ativos a partir de plantas medicinais. Conceitos sobre modificação estrutural para otimização da atividadeQuim. Nova1998211[Google Scholar]
  • 16. CzinnerE.HagymasiK.BlazovicsA.KeryA.SzokeE.LemberkovicsE.The in vitro effect of Helichysi flos on microsomal lipid peroxidationJ. Ethnopharmacol.2001773135[PubMed][Google Scholar]
  • 17. HarborneJ.B.BaxterH.Handbook of Natural FlavonoidsWileyChichester, UK19992
  • 18. WilliamsC.A.GrayerR.J.Anthocyanins and other flavonoidsNat. Prod. Rep.200421539573[PubMed][Google Scholar]
  • 19. HarborneJ.B.WilliamsC.A.Advances in flavonoid research since 1992Phytochemistry200055481504[PubMed][Google Scholar]
  • 20. HassigA.LiangW.X.SchwablH.StampfliK.Flavonoids and tannins plant-based antioxidants with vitamin characterMed. Hypotheses199952479481[PubMed][Google Scholar]
  • 21. MartensS.MithoferA.Flavones and flavone synthasesPhytochemistry20056623992407[PubMed][Google Scholar]
  • 22. DewickP. M.Medicinal Natural Products: a biosynthetic approachJohn WileyChichester, UK2002150
  • 23. BuchananB.GruissemW.JonesR.Biochemistry & Molecular Biology of PlantsAmerican Society of PlantPhysiologists, USA20001304
  • 24. HavsteenB.H.The biochemistry and medical significance of the flavonoidsPharmacol. Ther.20029667202[PubMed][Google Scholar]
  • 25. BeecherG.R.Overview of dietary flavonoids: nomenclature, occurrence and intakeJ. Nutr.20031333248S3254S[PubMed][Google Scholar]
  • 26. RossJ.A.KasumDietary flavonoids: bioavailability, metabolic effects, and safetyAnnu. Rev. Nutr.2002221934[PubMed][Google Scholar]
  • 27. YangC.S.LandauJ.M.HuangM.T.NewmarkH.L.Inhibition of carcinogenesis by dietary polyphenolic compoundsAnnu. Rev. Nutr.200121381406[PubMed][Google Scholar]
  • 28. ManachC.MorandC.DemigneC.TexierO.RegeratF.RémésyC.Bioavailability of rutin and quercetin in ratsFEBS Lett.19974091216[PubMed][Google Scholar]
  • 29. CritchfieldJ.W.ButeraS.T.FolksT.M.Inhibition of HIV activation in latently infected cells by flavonoid compoundsAIDS Res. Hum. Retrovir.1996123946[PubMed][Google Scholar]
  • 30. CheongH.RyuS.Y.OakM.H.CheonS.H.YooG.S.KimK.M.Studies of structure activity relationship for the anti-allergic actionsArch. Pharmacal Res.199821478480[PubMed][Google Scholar]
  • 31. CarotenutoA.FattorussoE.LanzottiV.MagnoS.De FeoV.CicalaC.The flavonoids of Allium neapolitanumPhytochemistry199744949957[PubMed][Google Scholar]
  • 32. LimaJ.T.AlmeidaJ.R.G.S.Barbosa-FilhoJ.M.AssisT.S.SilvaM.S.Da­cunhaE.V.L.Braz-FilhoR.SilvaB.A.Spasmolytic action of diplotropin, a furanoflavan from Diplotropis ferruginea Benth., involves calcium blockade in ginea-pig ileumZ. Naturforsch. B20056018[Google Scholar]
  • 33. Di CarloG.AutoreG.IzzoA.A.MaiolinoP.MascoloN.ViolaP.DiurnoM.V.CapassoF.Inhibition of intestinal motility and secretion by flavonoids in mice and rats: structure-activity relationshipsJ. Pharm. Pharmacol.19934510541059[PubMed][Google Scholar]
  • 34. La CasaC.VillegasI.Alarcon De La LastraC.MotilvaV.Martin CaleroM.J.Evidence for protective and antioxidant properties of rutin, a natural flavone, against ethanol induced gastric LesionsJ. Ethnopharmacol.2000714553[PubMed][Google Scholar]
  • 35. BarnaulovO.D.ManichevaO.A.KomissarenkoN.F.Comparative evaluation of the effect of some flavonoids on changes in the gastric wall of reserpine-treated or immobilized micePharm Chem.198317946951[Google Scholar]
  • 36. BarnaulovO.D.ManichevaO.A.ShelyutoV.L.KonoplevaM.M.GlyzinV.I.Effect of flavonoids on development of experimental gastric dystrophies in miceKhim Farm Zh.198518935941[Google Scholar]
  • 37. IzzoA.A.Di CarloG.MascoloN.CapassoF.Antiulcer effect of flavonoids: role of endogenous PAFPhytother Res.19948179181[Google Scholar]
  • 38. HiranoH.TakaseH.YamamotoK.AbeK.SaitoJ.Nobiletin as ulcer inhibitorPatent-Japan Kokai Tokkyo Koho-06 721994870, 4[Google Scholar]
  • 39. LarsonR.A.The antioxidants of higher plantsPhytochemistry199827969978[Google Scholar]
  • 40. SahuS.Pro-oxidant activity of flavonoids: effects on glutathione and glutathione S-transferase in isolated rat liver nucleiCat. Inist.1996104193196[Google Scholar]
  • 41. YoshinoK.SuzukiM.SasakiK.MiyaseT.SanoM.Formation of antioxidants from (-)-epigallocatechin gallate in mild alkaline fluids, such as authentic intestinal juice and mouse plasmaJ. Nutr. Biochem.199910223229[PubMed][Google Scholar]
  • 42. KyogokuK.HatayamaK.YokomoriS.SazikiR.NakaneS.SasajimaM.SawadaJ.OhzekiM.TanakaI.Anti-ulcer effect of isoprenyl flavonoids. II. Synthesis and anti-ulcer activity of new chalcones related to sophoradinChem. Pharm. Bull.19792729432953[PubMed][Google Scholar]
  • 43. SasajimaM.NakaneS.SazikiR.SaotomeH.HatayamaK.KyogokuK.TanakaI.Studies on the anti-ulcer effects of isoprenyl flavonoids. I. The anti-ulcer effects of isoprenyl chalcone extracted from Sophora subprostrataNippon Yakurigaku Zasshi197874897905[PubMed][Google Scholar]
  • 44. KimuraM.SazikiR.AraiI.TarumotoY.NakaneS.Effect of z-carboxymethoxy-4,4'-bis (3-methyl-2-butenyloxy) chalcone (sofalcone) on chronic gastric ulcers in ratsJPN. J. Pharmacol.198435389396[PubMed][Google Scholar]
  • 45. SazikiR.KyogokuK.HatayamaK.SuwaT.SawadaJ.Anti-ulcer activities of su-88, a compound related to sophoradin isolated from guang-dou-genJ. Pharmacobio-Dynam.19836S-59[Google Scholar]
  • 46. SazikiR.AraiI.IsobeY.HiroseH.AiharaH.Effects of sofalcone on necrotizing agents-induced gastric lesions and on endogenous prostaglandins in rat stomachsJ. Pharmacobio-Dynam.19847791797[Google Scholar]
  • 47. SunairiM.WatanabeK.SuzukiT.TanakaN.KuwayamaH.NakajimaM.Effects of anti-ulcer agents on antibiotic activity against Helicobacter pyloriEur J Gastroenterol Hepatol.19946Suppl 1S121S124[PubMed][Google Scholar]
  • 48. NagateT.NumataK.HanadaK.KondoI.The susceptibility of Campylobacter pylori to agents and antibioticsJ Clin Gastroenterol.199012Suppl 1S135S138[PubMed][Google Scholar]
  • 49. IsomotoH.FurusuH.OhnitaK.WenChun-Yang.InoueK.KohnoS.Sofalcone, a mucoprotective agent, increases the cure rate of Helicobacter pylori infection when combined with rabeprazole, amoxicillin and clarithromycinWorld J. Gastroenterol.20051116291633[PubMed][Google Scholar]
  • 50. LewisD.A.FieldsW.N.ShawG.P.A natural flavonoid present in unripe plantain banana pulp (Musa sapientum L. var. paradisiaca) protects the gastric mucosa from aspirin-induced erosionsJ. Ethnopharmacol.199965283288[PubMed][Google Scholar]
  • 51. LewisD.A.ShawG.P.A natural flavonoid and synthetic analogues protect the gastric mucosa from aspirin-induced erosionsJ. Nutr. Biochem.20011295100[PubMed][Google Scholar]
  • 52. YamaguchiF.SaitoM.ArigaT.YoshimuraY.NakazawaH.Free radical scavenging activity and antiulcer activity of garcinol from Garcinia indica Fruit RindJ. Agric. Food Chem.20004823202325[PubMed][Google Scholar]
  • 53. GuerreroC.P.MartinM.J.MarhuendaE.Prevention by rutin of gastric lesions induced by ethanol in rats, role of endogenous prostaglandinsGen. Pharmacol.199425575580[PubMed][Google Scholar]
  • 54. RaoC.V.GovindarajanS.K.O.R.RawatA.K.S.MehrotraS.PushpangadanP.Quercetin, a bioflavonoid, protects against oxidative stress-related gastric mucosal damage in ratsNat. Prod. Sci.200396872[Google Scholar]
  • 55. BarnaulovO.D.ManichevaO.A.YasinovR.K.YakovlevG.P.Evaluation of the effect of flavonoids from the aerial parts of Astragalus quisqualis bunge and A. floccosifolius sumn on the development of experimental lesions in the mouse stomachRast. Resur.218590[Google Scholar]
  • 56. MartinM.J.MotilvaV.Alarcon De La LastraC.Quercetin and naringenin, effects on ulcer formation and gastric secretion in ratsPhytother. Res.19937150153[PubMed][Google Scholar]
  • 57. BarnaulovO.D.ManichevaO.A.ZapesochnayaG.G.ShelyutoV.L.GlyzinV.I.Effects of certain flavonoids on the ulcerogenic action of reserpine in miceKhim. Farm. Zh.198216300303[Google Scholar]
  • 58. Alarcon De La LastraC.MartinM.J.MotilvaV.Antiulcer and gastroprotective effects of quercetin., a gross and histologic studyPharmacology1994485662[PubMed][Google Scholar]
  • 59. MartinM.J.La-CasaC.Alarcon De La LastraC.CabezaJ.VillegasI.MotilvaV.Anti-oxidant mechanisms involved in gastroprotective effects of quercetinZ. Naturforsch. C J. Biosci.1998538288[Google Scholar]
  • 60. KahramanA.ErkasapN.KokenT.SerteserM.AktepeF.ErkasapS.The antioxidative and antihistaminic properties of quercetin in ethanol-induced gastric lesionsToxicology2003183133142[PubMed][Google Scholar]
  • 61. BeilW.BirkhoizC.SewingK.F.Effects of flavonoids on parietal cell acid secretion, gastric mucosal prostaglandin production and Helicobacter pylori growthArzneim. Forsch.199545697700[PubMed][Google Scholar]
  • 62. MotilvaV.Alarcon De La LastraC.CaleroM.J.M.Effects of naringenin and quercetin on experimental chronic gastric ulcer in rat studies on the histological findingsPhytother. Res.19926168170[Google Scholar]
  • 63. RussoA.AcquavivaR.CampisiA.SorrentiV.Di GiacomoC.VirgataG.BarcellonaM.L.VanellaA.Bioflavonoids as antiradicals, antioxidants and DNA cleavage protectorsCell Biol. Toxicol.2000169198[PubMed][Google Scholar]
  • 64. PiettaP.G.Flavonoids as antioxidantJ. Nat. Prod.20006210351042[PubMed][Google Scholar]
  • 65. YamamotoK.KakegawaH.UedaH.MatsumotoH.SudoT.MikiT.SatohT.Gastric cytoprotective anti-ulcerogenic actions of hydroxychalcones in ratsPlanta Med.199258389393[PubMed][Google Scholar]
  • 66. OrtegaC.A.MariaA.O.M.GianelloJ.C.Chemical components and biological activity of Bidens subalternans, B. aurea (Astereaceae) and Zuccagnia puntacta (Fabaceae)Molecules20005465467[Google Scholar]
  • 67. De La RochaN.MariaA.O.M.GianelloJ.C.PelzerL.Cytoprotective effects of chalcones from Zuccagnia punctata and melatonin on the gastroduodenal tract in ratsPharmacol. Res.2003489799[PubMed][Google Scholar]
  • 68. KyogokuK.HatayamaK.YokomoriS.SekiT.IsoprenylchalconesPatent-Japan Kokai-75197524257[Google Scholar]
  • 69. KyogokuK.HatayamaK.YokomoriS.SekiT.IsoprenylchalconesPatent Japan Kokai 751975b24258[Google Scholar]
  • 70. HatayamaK.YokomoriS.KawashimaY.SazikiR.KyogokuK.Anti-ulcer effect of isoprenyl flavonoids. III. Synthesis and anti-ulcer activity of metabolites of 2'-carboxymethoxy-4,4'-Bis(3-methyl-2-butenyloxy) chalconeChem. Pharm. Bull.19853313271333[PubMed][Google Scholar]
  • 71. MurakamiS.KotomoS.OzawaM.BabaK.Novel chalcone derivative as antiulcer agentPatent Japan Kokai Koho 04199229968[Google Scholar]
  • 72. ParmarS.HenningsG.Perfect of 3-methoxy-5,7,3'4'-tetrahydroxyflavan on the healing of restraint ulcers in albino ratsIRCS Med. Sci-Biochem.198412393394[Google Scholar]
  • 73. KyogokuK.TachiY.HatayamaK.OhtakeT.Novel flavanone from Sophora angustifoliaPatent Japan Kokai 741974126809[Google Scholar]
  • 74. SuarezJ.HerreraM.D.MarhuendaE.Hesperidin and neohesperidin dihydrochalcone on different experimental models of induced gastric ulcerPhytother. Res.199610616618[PubMed][Google Scholar]
  • 75. ParmarN.S.The Gastric Anti-Ulcer Activity of Naringenin, a specific histidine decarboxylase inhibitorInt. J. Tissue React.19845415420[Google Scholar]
  • 76. GalatiE.M.MonforteM.T.D'aquinoA.MiceliN.Di MauroD.SanogoR.Effects of naringin on experimental ulcer in ratsPhytomedicine19985361366[PubMed][Google Scholar]
  • 77. MartinM.J.MarhuendaE.Perez-GuerreroC.FrancoJ.M.Antiulcer effect of naringin on gastric lesions induced by ethanol in ratsPharmacology199449144150[PubMed][Google Scholar]
  • 78. FomumZ.T.AyaforJ.F.MbafortjMbiC.N.Erythrina studies. Part 6. Pharmacological studies on sigmoidin a, b and c, novel flavanones isolated from Erythrina sigmoideaRev. Sci. Technol. (Health Sci. Ser.)198415568[Google Scholar]
  • 79. SaitoM.HosoyamaH.ArigaT.KataokaS.YamajiN.Antiulcer activity of grape seed extract and procyanidinsJ. Agric. Food Chem.19984614601464[PubMed][Google Scholar]
  • 80. ParmarN.S.GhoshM.N.The antiinflammatory and anti-gastric ulcer activities of some bioflavonoids. Bull Jawaharlal Inst. Post-GradMed. Educ. Res.19761611[Google Scholar]
  • 81. EzakiN.KatoM.TakizawaN.MorimotoS.NonakaG.I.NishiokaI.Pharmacological studies on linderae umbellatae ramus, IV. Effects of condensed tannin related compounds on peptic activity and stress-induced gastric lesions in micePlanta Med.1985513438[PubMed][Google Scholar]
  • 82. YamazakiM.OkuyamaE.MatsudoT.TakamaruT.KanekoT.Principles of indonesian herbal drugs having an antiulcerogenic activity. I. Isolation and identification of (+)-catechin from Artocarpus integra merrYakugaku Zasshi.1987107914916[PubMed][Google Scholar]
  • 83. ParmarN.S.GhoshM.N.Gastric antiulcer activity of methyl-3-(+)-catechinStud. Org. Chem. (Amsteram).198211513521[Google Scholar]
  • 84. BalintG. A.GaborM.NafradiJ.VarroV.Interaction of 3-o-mehtyl-(+)-catechin and H2-receptor blockers in piroxican- and indomethacin-induced gastric ulcer models of ratStud. Org. Chem.198523453456[Google Scholar]
  • 85. ParmarN.S.GhoshM.N.Gastric anti-ulcer activity of (+)-cyanidanol-3, a histidine decarboxylase inhibitorEur. J. Pharmacol.1981692532[PubMed][Google Scholar]
  • 86. KolhirV.K.BykovV.A.BaginskajaA.I.SokolovS.Y.GlazovaN.G.LeskovaT.E.SakovichG.S.TjukavkinaN.A.KolesnikY.A.RulenkoI.A.Antioxidant activity of a dihydroquercetin isolated from Larix gmelinii(Rupr.) Rupr. woodPhytother. Res.199610478482[Google Scholar]
  • 87. MagistrettiM.J.ContiM.CristoniA.Antiulcer activity of an anthocyanidin from Vaccinium myrtillusArzneim. Forsch.198838686690[PubMed][Google Scholar]
  • 88. RainovaL.NakovN.BogdanovaS.MinkovE.Staneva-StoytchevaD.Ulceroprotective activity of the flavonoids of Genista rumelica VelPhytother. Res.19882137139[PubMed][Google Scholar]
  • 89. LeeE.B.KangS.S.Antigastritis and antiulcer agent containing eupatilin, and isolation thereofPatent Repub. Korea1994127777[Google Scholar]
  • 90. VillarA.GascoM.A.AlcarazM.J.Anti-inflammatory and anti-ulcer properties of hypolaetin-8-glucoside, a novel plant flavonoidJ. Pharm. Pharmacol.198436820823[PubMed][Google Scholar]
  • 91. VillarA.GascoM.A.AlcarazM.J.ManezS.CortesD.Hypolaetin-8-o-glucoside, an anti-inflammatory flavonoid from Sideritis mugronensisPlanta Med.1985517071[PubMed][Google Scholar]
  • 92. AlcarazM.J.TorderaM.Studies on the gastric anti-ulcer activity of hypolaetin-8-glucosidePhytother. Res.198828588[PubMed][Google Scholar]
  • 93. TakaseH.YamamotoK.HiranoH.SaitoY.YamashitaA.Pharmacological profile of gastric mucosal protection by marmin and nobiletin from a traditional herbal medicine, Aurantii fructus immaturusJPN J. Pharmacol.199466139147[PubMed][Google Scholar]
  • 94. HiranoH.TakaseH.YamamotoK.YanaseT.AbeK.SaitoY.The anti-ulcer effects of Aurantii fructus immaturus, Aurantii fructus and the principles in Aurantii fructus immaturusNat. Med.199751190193[Google Scholar]
  • 95. CenD.Y.ChenZ.W.WangY.L.WangQ.LiQ.J.SongB.W.Protective effects of rutoside on gastric mucosa and influence on nitric oxide and prostaglandinChin. Pharm. Bull.199915360362[Google Scholar]
  • 96. MengD.S.WnagS.L.Protective effects of quercetin, rutoside, and flavone against intestinal mucosal injury induced by burns in miceChin. Pharm. Bull.200016673675[Google Scholar]
  • 97. OkuyamaE.YamazakiM.IshiiY.Isolation and identification of ursolic acid-related compounds as the principles of glechoma hederacea having an antiulcerogenic activityShoyakugaku zasshi1983375255[Google Scholar]
  • 98. RaoV.S.N.SantosF.A.SobrieraT.T.SouzaM.F.MeloC.L.SilveiraE.R.Investigations on the gastroprotective and antidiarrhoeal properties of ternatin, a tetramethoxyflavone from Egletes viscosaPlanta Med.199763146149[PubMed][Google Scholar]
  • 99. YamaharaJ.MochizukiM.ChisakaT.FujimuraH.TamaiY.The antiulcer action of sophora and the active constituent in sophora. II. The antiulcer action of vexibinolChem. Pharm. Bull.19903810391044[PubMed][Google Scholar]
  • 100. GoelR.K.MaitiR.N.TavaresI.A.Role of endogenous eicosanoids in the antiucler effect of kaempferolFitoterapia199667548552[Google Scholar]
  • 101. GoelR.K.PandeyV.B.DwivediS.P.D.RaoY.V.Antiinflammatory and antiulcer effects of kaempferol, a flavone, isolated from Rhamnus procumbensIndian J. Exp. Bio.261988121124[Google Scholar]
  • 102. Di CarloG.MascoloN.IzzoA.A.CapassoF.Effects of quercetin on the gastrointestinal tract in rats and micePhytother. Res.199484245[Google Scholar]
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.